Yet 44% of the high-risk patients, from LAAO’s early era, died by 5 years—researchers say this knowledge can aid ...

The new advisory focuses on confusion over what qualifies as ultraprocessed food and offers up policy-change strategies.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

New US hypertension guidelines, the first since 2017, released today reinforce prior recommendations that prioritize lowering ...

The study can’t supplant an RCT in this space, but does provide clear support for both short DAPT and P2Y12 inhibitors ...

Continuing the conversation, Juan Granada hears about Guido Ascione’s recent presentation on the global burden of ...

Juan Granada speaks with Greg Roth about how the GBD data set is used to assess global trends and determine what health problems need to be addressed by the medical community worldwide.

Johanne Silvain, Gilles Montalescot, and C. Michael Gibson discuss the effects of beta-blocker interruption in post-MI ...

Japanese registry data point to fewer deaths and heart failure hospitalizations, especially when MR is reduced to mild or ...

Effects are more modest in placebo-controlled versus nonrandomized studies, with experts calling for further research.

The advantage over balloon angioplasty in this higher-risk subset was consistent with the results seen in single-layer ISR.

The findings are encouraging but likely don’t apply to countries with ready access to thrombectomy, one expert says.